NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...

Low levels of vitamin D and its principal circulating form 25-hydroxyvitamin D (25-OH-D) have been linked to many types of adverse outcomes beyond bone health, such as cardiovascular disease. How ...

CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

Dr Ray O’Connor contines his look at recent clinical articles on therapeutics, particlularly in the fields of cardiology, and ...

Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...

Ford's small-block V8 engines had impressive specs and performance. Some models were used for decades while others powered ...

This play against the Oklahoma City Thunder is a perfect example, as Coward gets an angle on Brooks Barnhizer in transition ...

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...

New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to improvements in ...

A well-tolerated antisense oligonucleotide yielded significant reductions in severe hypertriglyceridemia while lowering risk for acute pancreatitis in two phase 3 trials.